Next Article in Journal
Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
Next Article in Special Issue
Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease
Previous Article in Journal / Special Issue
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Article Menu

Export Article

Pharmaceuticals 2009, 2(3), 287-298; doi:10.3390/ph2030287
Open AccessReview

Notes on Article Versions

Action Date Notes Link
article html file updated 18 January 2013 01:09 CET Original file -
article html file updated 21 January 2013 18:59 CET Update -
article html file updated 25 January 2013 20:35 CET Update -
article html file updated 28 January 2013 18:01 CET Update -
article html file updated 5 February 2013 20:23 CET Update -
article html file updated 6 February 2013 16:15 CET Update -
article xml file uploaded 28 April 2014 10:59 CEST Original file http://www.mdpi.com/1424-8247/2/3/287/xml
article html file updated 28 April 2014 10:59 CEST Update -
article html file updated 16 June 2015 07:47 CEST Update http://www.mdpi.com/1424-8247/2/3/287/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top